Wegovy, which was approved in 2021 for obesity, contains the same key ingredient as Ozempic, called semaglutide, while Mounjaro uses a slightly different one, tirzepatide
In this case, a cardiac electrophysiologist will perform the procedure
Ethical Approval This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors
This trend accelerated with tirzepatide gaining FDA approval for type 2 diabetes under the name Mounjaro in 2022, and subsequent approval of Zepbound for chronic weight management in adults with obesity or overweight in 2023
Take your injection at the same time each week
Participants receiving doses of Retatrutide lost significant weight, with 28.3% weight reduction seen at the highest dosage